MicroRNA-29a Attenuates Diabetic Glomerular Injury through Modulating Cannabinoid Receptor 1 Signaling
Diabetic nephropathy often leads to end-stage renal disease and life-threatening morbidities. Simple control of risk factors is insufficient to prevent the progression of diabetic nephropathy, hence the need for discovering new treatments is of paramount importance. Recently, the dysregulation of mi...
Main Authors: | Chun-Wu Tung, Cheng Ho, Yung-Chien Hsu, Shun-Chen Huang, Ya-Hsueh Shih, Chun-Liang Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-01-01
|
Series: | Molecules |
Subjects: | |
Online Access: | http://www.mdpi.com/1420-3049/24/2/264 |
Similar Items
-
Curcumin Reinforces MiR-29a Expression, Reducing Mesangial Fibrosis in a Model of Diabetic Fibrotic Kidney via Modulation of CB1R Signaling
by: Yung-Chien Hsu, et al.
Published: (2021-04-01) -
The Emerging Role of MicroRNAs in NAFLD: Highlight of MicroRNA-29a in Modulating Oxidative Stress, Inflammation, and Beyond
by: Hung-Yu Lin, et al.
Published: (2020-04-01) -
Development of An Oral Treatment with the PPAR-γ-Acting Cannabinoid VCE-003.2 Against the Inflammation-Driven Neuronal Deterioration in Experimental Parkinson’s Disease
by: Sonia Burgaz, et al.
Published: (2019-07-01) -
MicroRNA-29a Promotes Pancreatic Cancer Growth by Inhibiting Tristetraprolin
by: Xian-Jun Sun, et al.
Published: (2015-09-01) -
Angiotensin II-induced muscle atrophy via PPARγ suppression is mediated by miR-29b
by: Jin Li, et al.
Published: (2021-03-01)